Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Pulmonary Pharmacology & Therapeutics|December 4, 2019
Real-world evaluation of the clinical safety and efficacy of fluticasone/formoterol FDC via the Revolizer® in patients with persistent asthma in IndiaAloke Ghoshal, Pradyut Waghray, George Dsouza, et al.
Cureus|March 9, 2026
Beyond the Needle: Reimagining Insulin Delivery and the Evolution of Inhaled InsulinsPrasanna Kumar K M, Vijay Viswanathan, Banshi Saboo, et al.
Respiratory Medicine|February 15, 2020
Device-handling study of a novel breath-actuated inhaler, Synchrobreathe®, versus a pMDISanthalingam Balamurugan, Komalkirti Apte, Bhanu Pratap Singh, et al.
Lung India : Official Organ of Indian Chest Society|January 11, 2023
Efficacy and safety of glycopyrronium/formoterol delivered via a dry powder inhaler in patients with moderate to severe chronic obstructive pulmonary disease: Results from a multi-centre, open-label, randomised studySundeep Salvi, Anand Kumar, Sumit Agrawal, et al.
Pulmonary Pharmacology & Therapeutics|August 11, 2020
Fixed-dose combination of three drugs, i.e. LABA/LAMA/ICS for COPD: Results of a real-world study from IndiaSundeep Salvi, Ashish Kumar Deb, Mayank Agarwal, et al.
The Lancet. HIV|June 30, 2025
Safety, tolerability, and pharmacokinetics of an annual tenofovir alafenamide silicone subdermal implant in South African women: a two-part, randomised, placebo-controlled, double-blind, first-in-human, phase 1 trialTanuja N Gengiah, Lara Lewis, Ishana Harkoo, et al.
The European Respiratory Journal|July 16, 2026
Safety and efficacy of inhaled itraconazole in adults with asthma and allergic bronchopulmonary aspergillosis (PUR1900-ABPA): a randomized, double-blind, parallel group, placebo-controlled, multicenter, phase 2 trialRitesh Agarwal, Dhruv Chaudhary, Shyam Narain Gupta, et al.
Pageof 7